Health & Safety Programs Development & New Facility Planning for Indiana Biosciences Research Institute

Overview:

IBRI.png

The Indiana Biosciences Research Institute (IBRI) brings together life sciences companies and research universities to collaborate on efforts to improve human health in the U.S. and around the world. In 2018, the IBRI chose KERAMIDA to provide on-site safety compliance leadership resulting in the development and implementation of a state-of-the-art Health and Safety program that incorporates pharmaceutical industry and management system best practices. In addition, KERAMIDA provided health and safety expertise and review during the planning of the new IBRI facility.

Project Details:

Health & Safety Programs Development

KERAMIDA reviewed the IBRI’s existing Health & Safety programs and prepared a Health & Safety Audit Report to document any potential regulatory findings. It also included effective management practice recommendations for corrective action. In addition to assessing current programming, KERAMIDA produced a Health & Safety training program for visitors, contractors, new employee orientation, and ongoing employee training.

Recognizing that making Health and Safety a priority requires a team effort, KERAMIDA established an IBRI Safety Committee to sustain and build upon the Health & Safety program. In 2018, KERAMIDA began performing on-site monthly safety inspections of the IBRI facilities. KERAMIDA then provided the IBRI a summary of the findings of these inspections and worked through the Safety Committee to facilitate effective corrections.

KERAMIDA provided on-call consultation and support, including in-person site visits to address Health & Safety concerns or to be present during site audits or inspections. KERAMIDA also recommended strategic initiatives to enhance the IBRI’s Health & Safety programs and goals.

Health & Safety Planning for New Facility

Rendering of New IBRI Campus at 16 Tech

Rendering of New IBRI Campus at 16 Tech

The IBRI’s previous laboratories and offices were housed in approximately 20,000 square feet of leased space in the Indiana University School of Medicine’s Biotechnology Research and Training Center in Indianapolis. The IBRI’s new facility is 68,000 square feet of the new Advanced Research and Innovation Building in 16 Tech, an urban innovation district being developed in the historic Riverside neighborhood of Indianapolis. The new IBRI facility includes office, innovation, collaboration, and laboratory space.

KERAMIDA’s health and safety professionals participated in planning and review of health and safety aspects of the new IBRI facility, including consultation with building design engineers.


Related Services: